LENALIDOMIDE | LENALIDOMIDE | ATC L04AX04
ANTINEOPLASTIC THALIDOMIDE ANALOG POSSESSES IMMUNOMODULATORY, ANTIANGIOGENIC, AND ANTINEOPLASTIC PROPERTIES TARGET NOT KNOWN TREATMENT OF MULTIPLE MYELOMA (MM) | ORAL | Tmax 3.25 HOUR PPB 30 PERCENT HT 3 HOUR SOLUBILITY SOLUBLE IN ORGANIC SOLVENT/WATER MIXTURES | PDB 5FQD (STRUCTURAL BASIS OF LENALIDOMIDE INDUCED CK1A DEGRADATION BY THE CRL4CRBN UBIQUITIN LIGASE) LIGAND CODE = LVY (link to the list of PDB complexes) Download experimental 3D coordinates of LVY with added hydrogens | Protein cereblon UNIPROT Q96SW2 CRBN more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |